
-
Altomare hangs on to tie defending champ Korda at LPGA Match Play
-
Paraguay gold rush leaves tea producers bitter
-
Health concerns swirl as Bolivian city drowns in rubbish
-
Syria says deadly Israeli strikes a 'blatant violation'
-
Financial markets tumble after Trump tariff announcement
-
Starbucks faces new hot spill lawsuits weeks after $50mn ruling
-
Europe riled, but plans cool-headed response to Trump's tariffs
-
'Shenmue' voted most influential video game ever in UK poll
-
New coal capacity hit 20-year low in 2024: report
-
Revealed: Why monkeys are better at yodelling than humans
-
Key details on Trump's market-shaking tariffs
-
'A little tough love': Top quotes from Trump tariff talk
-
US business groups voice dismay at Trump's new tariffs
-
Grealish dedicates Man City goal to late brother
-
US tariffs take aim everywhere, including uninhabited islands
-
Trump sparks trade war with sweeping global tariffs
-
Israeli strikes hit Damascus, central Syria; monitor says 4 dead
-
Slot 'hates' offside rule that gave Liverpool win over Everton
-
US stocks end up, but volatility ahead after latest Trump tariffs
-
Barca oust Atletico to set up Clasico Copa del Rey final
-
Mourinho grabs Galatasaray coach's face after losing Istanbul derby
-
Grealish strikes early as Man City move up to fourth in Premier League
-
Reims edge out fourth-tier Cannes to set up PSG French Cup final
-
Liverpool beat Everton as title looms, Man City win without Haaland
-
Jota wins bad-tempered derby as Liverpool move 12 points clear
-
Inter and Milan level in derby Italian Cup semi
-
Stuttgart beat Leipzig to reach German Cup final
-
Trump unveils sweeping global tariffs
-
Italian director Nanni Moretti in hospital after heart attack: media
-
LIV Golf stars playing at Doral with Masters on their minds
-
Trump unveils sweeping 'Liberation Day' tariffs
-
Most deadly 2024 hurricane names retired from use: UN agency
-
Boeing chief reports progress to Senate panel after 'serious missteps'
-
Is Musk's political career descending to Earth?
-
On Mexico-US border, Trump's 'Liberation Day' brings fears for future
-
Starbucks faces new hot spill lawsuit weeks after $50mn ruling
-
Ally of Pope Francis elected France's top bishop
-
'Determined' Buttler leads Gujarat to IPL win over Bengaluru
-
US judge dismisses corruption case against New York mayor
-
Left-wing party pulls ahead in Greenland municipal elections
-
Blistering Buttler leads Gujarat to IPL win over Bengaluru
-
Tesla sales slump as pressure piles on Musk
-
Amazon makes last-minute bid for TikTok: report
-
Canada Conservative leader warns Trump could break future trade deal
-
British band Muse cancels planned Istanbul gig
-
'I'll be back' vows Haaland after injury blow
-
Trump to unveil 'Liberation Day' tariffs as world braces
-
New coach Edwards adamant England can win women's cricket World Cup
-
Military confrontation 'almost inevitable' if Iran nuclear talks fail: French FM
-
US stocks advance ahead of looming Trump tariffs

Seventh person likely 'cured' of HIV, doctors announce
A 60-year-old German man is likely the seventh person to be effectively cured from HIV after receiving a stem cell transplant, doctors announced on Thursday.
The painful and risky procedure is for people who have both HIV and aggressive leukaemia, so is not an option for almost all of the nearly 40 million people living with the deadly virus across the world.
The German man, whose wished to remain anonymous, was dubbed the "next Berlin patient".
The original Berlin patient, Timothy Ray Brown, was the first person declared cured of HIV back in 2008. Brown died from cancer in 2020.
The second man from Berlin to achieve long-term HIV remission was announced ahead of the 25th International AIDS Conference being held in the German city of Munich next week.
He was first diagnosed with HIV in 2009, according to the research abstract being presented at the conference.
The man received a bone marrow transplant for his leukaemia in 2015. The procedure, which has a 10 percent risk of death, essentially replaces a person's immune system.
Then he stopped taking anti-retroviral drugs -- which reduce the amount of HIV in the blood -- in late 2018.
Nearly six years later, he appears to be both HIV and cancer free, the medical researchers said.
Christian Gaebler, a doctor-researcher at Berlin's Charite university hospital treating the patient, told AFP that the team cannot be "absolutely certain" every last trace of HIV has been eradicated.
But "the patient's case is highly suggestive of an HIV cure," Gaebler added. "He feels well and is enthusiastic about contributing to our research efforts."
- 'Promising' for wider cure -
International AIDS Society President Sharon Lewin said researchers hesitate to use the word "cure" because it is not clear how long they need to follow up such cases.
But more than five years in remission means the man "would be close" to being considered cured, she told a press conference.
There is an important difference between the man's case and the other HIV patients who have reached long-term remission, she said.
All but one of the other patients received stem cells from donors with a rare mutation in which part of their CCR5 gene was missing, blocking HIV from entering their body's cells.
Those donors had inherited two copies of the mutated CCR5 gene -- one from each parent -- making them "essentially immune" to HIV, Lewin said.
But the new Berlin patient is the first to have received stem cells from a donor who had inherited only one copy of the mutated gene.
Around 15 percent of people from European origin have one mutated copy, compared to one percent for both.
Researchers hope the latest success means there will be a much larger potential donor pool in the future.
The new case is also "promising" for the wider search for an HIV cure that works for all patients, Lewin said.
This is "because it suggests that you don't actually have to get rid of every single piece of CCR5 for gene therapy to work," she added.
The Geneva patient, whose case was announced at last year's AIDS conference, is the other exception among the seven. He received a transplant from a donor without any CCR5 mutations -- yet still achieved long-term remission.
This showed that the effectiveness of the procedure was not just down to the CCR5 gene, Lewin said.
Ch.Havering--AMWN